On Wednesday, in the course of current trade, Shares of Paypal Holdings Inc (NASDAQ:PYPL), climbed 1.36%, and is now trading at $39.48.
PayPal Holdings, declared John D. Rainey is joining the digital payments leader as its new Chief Financial Officer (CFO), effective August 24, 2015. Rainey joins PayPal from United Continental Holdings, Inc. where he was Executive Vice President and CFO at United Airlines. Rainey brings with him an extensive background in corporate finance, treasury, financial planning and analysis, tax, investor relations, planned planning and risk administration together with a deep appreciation for PayPal and its unique position driving the global transformation of money.
“I couldn’t be more thrilled to welcome John to PayPal where he will undoubtedly make an immediate impact as we start operating as an independent and publicly traded company,” said Dan Schulman, president and CEO of PayPal. “I am particularly impressed with John’s ability to lead a financial function in a complex, industry-leading business, while maintaining an unrelenting focus on serving and advocating for his company’s customers. I believe that John and the entire PayPal team have an inspiring chance to provide financial freedom, flexibility and opportunity to millions of people worldwide.”
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants worldwide. It enables businesses of various sizes to accept payments from merchant Websites, mobile devices, and applications, in addition to at offline retail locations through a range of payment solutions across company’s payments platform, counting PayPal, PayPal Credit, Venmo, and Braintree products.
During an Afternoon trade, Shares of Seagate Technology PLC (NASDAQ:STX), dipped -0.45%, and is now trading at $51.15.
Seagate Technology plc, declared at Gamescom the new 2TB Game Drive for Xbox, the result of a planned marketing relationship with Microsoft. This new external drive is designed to complement the Xbox color scheme and is set up for an easy plug-and-play connection with an Xbox One or Xbox 360 gaming console.
“With all of the new and amazing titles predictable for this holiday season and a ton more games coming in the future, Xbox gamers will need even more storage and portability,” said Matt Kesselring, business development manager for Microsoft’s designed for Xbox partner program. “Microsoft is privileged to be working with Seagate as our trusted partner for this important designed for Xbox peripheral.”
Seagate Technology Public Limited Company designs, manufactures, and sells electronic data storage products in the Asia Pacific, the Americas, and EMEA countries. The company provides hard disk drives, solid state hybrid drives, and solid state drives that are designed for enterprise servers and storage systems in mission critical and nearline applications; for client compute applications comprising desktop and mobile computing; and for client non-compute applications, such as digital video recorders, personal data backup systems, portable external storage systems, and digital media systems.
Finally, Synthetic Biologics Inc (NYSEMKT:SYN), gained 0.31% Wednesday.
Aeterna Zentaris (AEZS), CytRx Corporation (CYTR), Synthetic Biologics Inc. (SYN) are three tickers that have attracted attention in the Biotech space.
Biotech has mimicked the dot com boom of the early 2000’s quite closely. Several biotech indices and ETFs have shown remarkable growth and have certainly outplaced the overall market. However, growth of this proportion leads to instabilities and overvaluation of many companies. This is exemplified in each of the three companies in focus. AEZS is trading near a 52 – week low after the company received disappointing results from the FDA. Similarly, CtyRx recently declared an offering in which administration offered shares at a noteworthydiscount to the market price which resulted in the declines in the stock price. The biotech sector is full of speculation and blind money has been attracted solely by the returns published by both ETFs and Indices that follow this sector. The growth rates will decline and the boom will fall back in line with the market, but some will standout and continue to achieve growth of tremendous proportions.
Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
